Skip to content
The wire
Wall Street
ASXASX 200 8,730 down -1.04%as at 20 Nov 2026, 5:53 am GMT+0800BHP Group (BHP) 51.40 AUD down -1.80%as at 20 Nov 2026, 1:54 pm GMT+0800Commonwealth Bank (CBA) 169.92 AUD down -1.00%as at 20 Nov 2026, 1:54 pm GMT+0800CommoditiesBrent Crude Oil (Brent Futures) 92.58 USD/bbl up +0.65%as at 21 Nov 2026, 6:40 am GMT+0800WTI Crude Oil (WTI Futures) 83.56 USD/bbl up +1.36%as at 21 Nov 2026, 6:40 am GMT+0800EuronextCAC 40 7,927.75 down -1.89%as at 21 Nov 2026, 6:40 am GMT+0800Euro StoxxEURO STOXX 50 5,936.85 down -2.90%as at 21 Nov 2026, 6:40 am GMT+0800FTSEFTSE 100 10,348.55 down -1.00%as at 21 Nov 2026, 6:40 am GMT+0800HKEXHANG SENG 22,410.80 down -1.89%as at 21 Nov 2026, 6:40 am GMT+0800NasdaqAlphabet (GOOGL) 265.29 USD down -2.70%as at 21 Nov 2026, 6:40 am GMT+0800Amazon (AMZN) 246.82 USD down -4.10%as at 21 Nov 2026, 6:40 am GMT+0800Apple (AAPL) 342.56 USD down -1.90%as at 21 Nov 2026, 6:40 am GMT+0800DOW JONES 48,147.33 down -1.93%as at 21 Nov 2026, 6:40 am GMT+0800Meta Platforms (META) 560.84 USD down -5.93%as at 21 Nov 2026, 6:40 am GMT+0800NASDAQ 22,617.73 down -5.28%as at 21 Nov 2026, 6:40 am GMT+0800S&P 500 6,910.39 down -3.70%as at 21 Nov 2026, 6:40 am GMT+0800Tesla (TSLA) 345.82 USD down -7.64%as at 21 Nov 2026, 6:40 am GMT+0800NSENIFTY 50 25,800.60 up +1.12%as at 21 Nov 2026, 6:40 am GMT+0800NYSEBerkshire Hathaway (BRK.B) 570.00 USD down -0.36%as at 21 Nov 2026, 6:40 am GMT+0800NZXNZX 50 14,107.41 down -0.98%as at 20 Nov 2026, 1:54 pm GMT+0800Russell 2000RUSSELL 2000 2,581.79 down -2.76%as at 21 Nov 2026, 6:40 am GMT+0800SSESHANGHAI COMPOSITE 3,533.79 down -1.22%as at 21 Nov 2026, 6:40 am GMT+0800TSENIKKEI 225 56,436.65 down -5.06%as at 21 Nov 2026, 6:40 am GMT+0800XetraDAX 40 24,782.95 down -2.67%as at 21 Nov 2026, 6:40 am GMT+0800CryptoBTC/USD 58,970.00 USD down -5.21%as at 21 Nov 2026, 6:40 am GMT+0800Ethereum (ETH/USD) 1,618.91 USD down -8.16%as at 21 Nov 2026, 6:40 am GMT+0800SOL/USD 68.960 USD down -5.75%as at 21 Nov 2026, 6:40 am GMT+0800XRP/USD 0.91172 USD down -5.28%as at 21 Nov 2026, 6:40 am GMT+0800ForexAUD/EUR 0.607100 EUR down -0.31%as at 20 Nov 2026, 1:54 pm GMT+0800AUD/GBP 0.508500 GBP up +0.02%as at 20 Nov 2026, 1:54 pm GMT+0800AUD/JPY 106.1100 JPY down -0.41%as at 20 Nov 2026, 1:54 pm GMT+0800AUD/NZD 1.212700 NZD down -0.18%as at 20 Nov 2026, 1:54 pm GMT+0800AUD/USD 0.666600 USD down -0.16%as at 20 Nov 2026, 1:54 pm GMT+0800EUR/GBP 0.837589 GBP up +0.33%as at 20 Nov 2026, 1:54 pm GMT+0800EUR/USD 1.098007 USD up +0.15%as at 20 Nov 2026, 1:54 pm GMT+0800GBP/USD 1.310914 USD down -0.18%as at 20 Nov 2026, 1:54 pm GMT+0800NZD/USD 0.549683 USD up +0.02%as at 20 Nov 2026, 1:54 pm GMT+0800USD/CAD 1.432343 CAD down -0.14%as at 20 Nov 2026, 1:54 pm GMT+0800USD/CHF 0.842034 CHF down -0.19%as at 20 Nov 2026, 1:54 pm GMT+0800USD/CNY 6.671617 CNY up +0.08%as at 20 Nov 2026, 1:54 pm GMT+0800USD/JPY 159.1809 JPY down -0.25%as at 20 Nov 2026, 1:54 pm GMT+0800
Rates
  • AURBA4.85%Next 8 Dec
  • USFed3.75-4.00%Next 10 Dec
  • UKBoE4.00%Next 17 Dec
  • EUECB2.50%Next 17 Dec
  • JPBoJ1.25%Next 18 Dec
  • CABoC2.50%Next 9 Dec
  • NZRBNZ2.75%Next 9 Dec
  • USUS CPI+0.4% m/mOct
  • USPayrolls+165,000 jobsOct 2026, seasonally adjusted monthly payroll change
  • USUS jobless4.1%Oct 2026, seasonally adjusted unemployment rate
  • USCore PCE3.1% y/ySep 2026, core PCE price index y/y
  • USUS GDP+3.4% annualisedQ3 2026, q/q seasonally adjusted annual rate
  • USUS retail+0.8% m/mSep 2026, m/m retail sales, seasonally adjusted
  • USISM mfg55.5Oct 2026, ISM manufacturing PMI index points
  • AUAU CPI4.3% y/ySep 2026, CPI y/y
  • AUAU jobless4.9%Oct 2026, seasonally adjusted unemployment
  • AUAU GDP+0.4% q/qQ2 2026, seasonally adjusted real GDP q/q
  • UKUK CPI3.6% y/yOct 2026, 12-month CPI
  • UKUK jobless4.7%Jun-Aug 2026, ILO unemployment
  • UKUK GDP+0.7% q/qQ3 2026, real GDP q/q
  • EUEZ CPI4.0% y/yOct 2026 euro-area HICP, flash estimate
  • CNChina GDP4.5% y/yQ3 2026, real GDP y/y
  • XAUGold4,052.40 USD/oz-1.49%
  • OILBrent99.69 USD/bbl+1.42%
  • OILWTI91.36 USD/bbl+0.11%
  • USUS 10Y4.837%-0.057 pts
  • VIXVIX28.18+69.66%
  • USDDXY101.768+0.21%
  • BTCBitcoin75,551.00 USD-6.09%
Sunday 22 November 2026A wider view Independent in spirit. Open by design.

The headline.
The whole story.

Live desk
On the agenda Baltic drone strikeParma shootingCOP31Bolsonaro in hospitalIran power cutsUS-Canada defence ties
Australia 3 min read

From five hospital visits a month to 217: Butler sends online peptide prescribing to a parliamentary inquiry

Health Minister Mark Butler has asked federal parliament's health committee to investigate how unapproved peptides are prescribed through telehealth, sold through one-stop online dispensaries and pushed on social media. Hearings are due to start this month, with a final report in mid-2027.

Valcored News Network © Valcored News. All rights reserved.

Three things to know

  1. Butler wrote to the House of Representatives Standing Committee on Health chair, Dr Mike Freelander, on Friday asking for the inquiry.
  2. NSW Health figures show monthly hospital visits linked to peptides rose from five in July 2025 to 217 in September 2026.
  3. Some peptides are approved medicines, including semaglutides such as Ozempic and Wegovy. The inquiry targets the unapproved products being prescribed and sold online.

The federal government has ordered a parliamentary inquiry into the booming online trade in unapproved peptides, after a sharp rise in hospital visits and poisoning calls linked to the injectable products.

Health Minister Mark Butler wrote on Friday to Dr Mike Freelander, who chairs the House of Representatives Standing Committee on Health, asking it to examine the safety and quality of online peptide prescribing. The request was made public on Sunday. Consultation hearings are expected to begin in November, and the committee is due to deliver its final report in mid-2027.

Butler said the products are marketed online as wonder drugs, but “can pose serious health risks to Australian consumers”.

What will the inquiry look at?

The committee has been asked to examine how common peptide prescribing has become, the benefits and risks of online and direct-to-consumer models of care, and the role that digital platforms and social media play in promoting peptide use.

Butler said he was extremely concerned by escalating reports from the Therapeutic Goods Administration (TGA) about unapproved peptides being prescribed through telehealth services and supplied by one-stop-shop dispensaries.

The TGA has reported a stark rise in the importation, supply, compounding and advertising of unapproved peptides through social media and telehealth.

How big is the problem?

The numbers have climbed fast. NSW Health figures show peptide-linked hospital visits in that state went from five a month in July 2025 to 217 in September 2026: more than seven a day.

The Australian Poisons Information Centre recorded 345 cases involving unapproved peptides in the first six months of 2026, more than three times the total for the whole of 2025.

In September the TGA said a person who had used unapproved peptides came close to dying from a potentially fatal tear in the oesophagus after uncontrollable vomiting.

Who is being targeted by the marketing?

The government’s Special Envoy for Men’s Health, Dan Repacholi, said he was particularly concerned about “young blokes” turning to unapproved products.

“Just because someone with a sixpack is promoting something online doesn’t mean it’s safe,” he said.

Sport Minister Anika Wells said peptides were an emerging risk for athletes, both to the integrity of sport and to their health.

Are all peptides unsafe?

No. Peptides are short chains of amino acids, and some are approved, prescription medicines. Semaglutides such as Ozempic and Wegovy, used for diabetes and weight loss, are peptide medicines approved in Australia.

The concern is the trade in products that have not been approved by the TGA, which are promoted for muscle growth, recovery, weight loss or anti-ageing and are often bought online with little or no medical oversight. The TGA has warned Australians against buying unapproved peptide products online, particularly from overseas websites or through social media.

Why does telehealth matter here?

Telehealth became a mainstream part of Australian medicine during the pandemic, and most of it is ordinary care. But the inquiry has been asked to look at business models where an online consultation and a dispensary sit under one roof, and a prescription can arrive with the product.

Independent MP Dr Monique Ryan, a medical doctor, has separately urged Butler to crack down on rogue telehealth clinics, saying GPs have raised concerns about telehealth prescribing of peptides and other drugs.

For readers, the practical message from regulators is unchanged: if a peptide is sold without a proper consultation with a doctor who knows your history, or is promoted by an influencer as a quick fix, treat it as a risk to your health.

What happens to the industry in the meantime?

Nothing changes in law until the committee reports and the government responds. The TGA can still act against unlawful advertising and supply under existing rules, and has been issuing warnings through 2026.

The Coalition has not yet said whether it supports the inquiry.

If you are worried about a product you have used, talk to your doctor, or call the Poisons Information Centre on 13 11 26.

How we got here

The key moments that brought this story into focus. Open any moment for detail.

  1. 2025Peptide visits begin to climb

    NSW Health records five peptide-linked hospital visits in July 2025.

  2. September 2026Near-fatal case

    The TGA reports a user of unapproved peptides nearly died from an oesophageal tear; NSW peptide-linked hospital visits reach 217 for the month.

  3. First half of 2026Poisoning calls triple

    The Australian Poisons Information Centre records 345 cases involving unapproved peptides.

  4. 20 November 2026Inquiry requested

    Mark Butler writes to health committee chair Mike Freelander.

  5. 22 November 2026Inquiry made public

    The government announces the inquiry, with hearings from November.

What happens next

The Standing Committee on Health is expected to call for submissions and begin consultation hearings in November, and to deliver its final report in mid-2027. The government will then decide whether to tighten rules on telehealth prescribing, online dispensaries and peptide advertising.

Sources

  • VNN

VNN never names people who give us information in confidence. How we protect sources and tips.

The headline. The whole story.

Spotted something we should check? Tell the newsroom.

Comments

0 comments

Community rules

To read and join the conversation, please agree to our rules.

  1. Be respectful. No insults, name-calling, harassment, threats or hate.
  2. No links, web addresses or email addresses of any kind.
  3. No spam, advertising or self-promotion.
  4. One comment per story. You can reply to other people's comments, and to replies on yours.
  5. Stay on topic and keep personal information private.
  6. Comments that break these rules are removed, and repeat offenders are blocked.

Accessibility

Change how this website looks and behaves for you. Your choices are saved in this browser on this device only.

Text

Text size100%

Colour and links

Movement and focus

Read and find your way

Jump to a section of this page

    Your browser and device also have accessibility settings, such as zoom (Ctrl or ⌘ and +), a screen reader and reduced motion. This website works with them.

    Your privacy choices

    We use cookies and similar technologies to run this website. With your permission, we would also use them for advertising and embedded videos and social media posts. You can change your mind at any time with “Cookie settings” at the bottom of every page. Cookies policy.

    Cookie settings

    Choose what you allow. Storage the website needs to work is always on. You can come back here at any time from “Cookie settings” at the bottom of every page.

    • Strictly necessary

      Security, signing in, payments you start, protection against ad fraud and remembering your cookie choice.

      Always on
      What is stored (10)
      • vnn_consent VNN (this website) · Cookie · 12 months
        Remembers your cookie choices so we do not ask on every page.
      • wordpress_logged_in_*, wordpress_sec_* WordPress (this website) · Cookie · Until you sign out, up to 14 days
        Keeps you signed in, if you have an account (VNN staff, subscribers and buyers).
      • wordpress_test_cookie WordPress (this website) · Cookie · Until you close the browser
        Checks your browser accepts cookies when you sign in.
      • wp-settings-*, wp-settings-time-* WordPress (this website) · Cookie · 1 year
        Remembers dashboard layout for VNN staff. Not set for readers.
      • vcn_co VNN (this website) · Cookie · 1 day
        Links a payment to the browser that made it, so a new reader is signed in straight away after paying.
      • vnn_rules VNN (this website) · Cookie · 1 year
        Remembers that you agreed to the community rules before commenting.
      • vnn.rules VNN (this website) · Local storage · Until you clear your browser data
        The same agreement, kept in your browser as a back-up.
      • vnn.adshield.block, vnn.adshield.clicks VNN (this website) · Local storage · Up to 24 hours
        Protects our advertisers from invalid clicks (ad fraud) by pausing ads after repeated clicks.
      • vnn.adshield.ok VNN (this website) · Session storage · Until you close the tab
        Avoids re-checking the click protection on every page.
      • Payment security cookies Our card payment processor · Cookie · Up to 1 year
        Set only on the payment page and the billing part of your account page, to protect card payments from fraud.
    • Your settings on this device

      Saved stories, followed topics and other settings you choose. Kept in your browser only.

      Always on
      What is stored (7)
      • vcn.saved-stories.v1 VNN (this website) · Local storage · Until you remove them
        The stories you save with the bookmark button.
      • vcn.followed-topics.v1 VNN (this website) · Local storage · Until you remove them
        The topics you choose to follow.
      • vnn.alert.dismissed VNN (this website) · Session storage · Until you close the tab
        Remembers that you closed the breaking-news bar.
      • vnn.access VNN (this website) · Local storage · Until you reset them
        Your accessibility settings, such as text size and contrast.
      • vnn.support VNN (this website) · Local storage · Until you clear your browser data
        Remembers when you closed the “Support VNN” panel or gave, so it does not keep appearing.
      • comment_author_*, comment_author_email_* WordPress (this website) · Cookie · About 1 year
        Fills in your name and email on the comment form, only if you tick “Save my name”.
      • vnn-app-* VNN (this website) · Cache storage (service worker) · Until the app updates or you clear site data
        The web app’s icons and offline page, so it opens quickly and can tell you when you are offline.
    • Advertising

      Lets our advertising partner show ads based on your interests and measure them. If you say no, you may still see ads, but they are not personalised.

      What is stored (1)
      • __gads, __gpi, __eoi and Google ad cookies (e.g. IDE on doubleclick.net) Google AdSense · Cookie · Up to 13 months (set by Google)
        Shows ads, limits how often you see the same ad, prevents fraud and measures results. Ads are personalised only if you accept advertising.
    • Embedded videos and posts

      Loads videos, social media posts and other content hosted by other companies, such as YouTube or X. They may set their own cookies. If you say no, each one waits until you choose to load it.

      What is stored (1)
      • Set by the provider YouTube, Vimeo, X (Twitter), Instagram, TikTok, Facebook, Spotify and other embedded services · Cookie · Set by the provider
        Plays videos and shows posts inside our stories. Nothing loads until you choose to load it or allow embedded content.

    Full details: Cookies policy.

    VNNVALCORED NEWS NETWORK

    Install the VNN web app

    Choose your device to see how to add VNN to your home screen.

      What is the VNN web app?

      It is this website, saved to your home screen so it opens like an app: full screen, one tap away, straight to the front page. It is free, there is no app store download, it uses almost no storage and it updates itself. To remove it, press and hold the VNN icon and choose Remove. What the web app stores on your device